EFEM
WST icon

Eos Focused Equity Management’s West Pharmaceutical WST Stock Holding History

Eos Focused Equity Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-49,830
Closed -$3M – 36
2015
Q4 		$3M Sell
49,830
-9,000
-15% -$541K 2.58% 19
2015
Q3 		$3.18M Buy
+58,830
New +$3.43M 2.94% 19

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Eos Focused Equity Management's WST Position: Q1 2016 in Review

Eos Focused Equity Management sold out of West Pharmaceutical (WST) in Q1 2016, closing a stake of 49,830 shares — an estimated $3M sold.

Eos Focused Equity Management first reported a position in WST in Q3 2015 and held it in 2 quarters. The position peaked at $3.18M in Q3 2015. 251 funds tracked by Wall St. Rank hold WST as of Q1 2016.

  • Eos Focused Equity Management reported no remaining West Pharmaceutical position as of Q1 2016 after selling out during the quarter.
  • Eos Focused Equity Management sold 49,830 West Pharmaceutical shares in Q1 2016, an estimated $3M.
  • Eos Focused Equity Management first reported a position in West Pharmaceutical in Q3 2015 and held it in 2 quarters.
  • Eos Focused Equity Management's West Pharmaceutical position peaked at $3.18M in Q3 2015.
  • 251 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2016.

Based on Eos Focused Equity Management's 13F filing for Q1 2016, filed 9 May 2016.